Evidence map›Paper›PMID 41179901›Full record

ArticleFrontiers in medicine2025

A novel closed chest drainage device.

Shaoqing Huang, Xu Song, Qiang Shi, Jie Li

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shaoqing HuangDepartment of Thoracic Surgery, Ningbo No. 2 Hospital, Ningbo, China.
Xu SongDepartment of Thoracic Surgery, Ningbo No. 2 Hospital, Ningbo, China.
Qiang ShiDepartment of Thoracic Surgery, Ningbo No. 2 Hospital, Ningbo, China.
Jie LiDepartment of Thoracic Surgery, Ningbo No. 2 Hospital, Ningbo, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Negative pressure closed thoracic drainage improves drainage efficiency, accelerates the removal of fluid and air, and facilitates lung re-expansion. Conventional wall negative pressure systems restrict patient mobility, while digital drainage devices are associated with high costs that hinder widespread clinical adoption. Hence, there is an urgent need for a cost-effective, practical, and portable negative pressure drainage system. Methods: Based on the principles outlined in the Chinese national patent (ZL 202122505281.4), we innovatively integrated a micro-pump and power system into a compact, portable negative pressure generator, which was then connected to the pressure-regulating chamber of a conventional three-chamber closed drainage bottle. This integration resulted in a novel portable closed thoracic drainage device with active negative pressure control. The device underwent Results: The test results indicate that the novel closed thoracic drainage device can achieve a maximum negative pressure of approximately 20 cm H₂O and a maximum airflow rate of 15 L/min. The novel device was initially used in three patients. Conclusion: A novel type of negative pressure closed thoracic drainage device has been successfully developed and a preliminary concept verification has been carried out. This device offers the advantages of cost-effectiveness and portability, demonstrating potential for wide application in postoperative thoracic drainage following lung surgery.

Indexed as

digital drainage devicelung surgerynegative pressure drainage devicenovel closed chest drainage devicetraditional closed chest drainage systems

Identifiers

PMID41179901
PMCPMC12577643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.